Heat shock protein–based therapy as a potential candidate for treating the sphingolipidoses

A SIMPLE METHOD FOR THE ISOLATION AND PURIFICATION OF TOTAL LIPIDES FROM ANIMAL TISSUES

Folch, J., Lees, M., & Stanley, G. H. S. (1957) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)64849-5 · Cited by 65,189 · see citing works

Repertoires of Autophagy in the Pathogenesis of Ocular Diseases

Li, Y., Jiang, Q. L., Cao, G.-F., Yao, J., & Yan, B. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000373980 · Cited by 16,351 · see citing works

Induction of the Vitamin D Receptor Attenuates Autophagy Dysfunction-Mediated Cell Death Following Traumatic Brain Injury

Cui, C., Cui, J., Jin, F., Cui, Y., Li, R., Jiang, X., Tian, Y., Wang, R. C., Jiang, P., & Gao, J. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000479571 · Cited by 5,214 · see citing works

Graphical Evaluation of Blood-to-Brain Transfer Constants from Multiple-Time Uptake Data

Patlak, C. S., Blasberg, R. G., & Fenstermacher, J. D. (1983) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1983.1 · Cited by 3,565 · see citing works

The role of autophagy in neurodegenerative disease

Nixon, R. A. (2013) · Nature Medicine · doi:10.1038/nm.3232 · Cited by 2,059 · see citing works

Niemann-Pick disease type C

Vanier, M. T. (2010) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-5-16 · Cited by 1,222 · see citing works

The heat shock protein 70 family: Highly homologous proteins with overlapping and distinct functions

Daugaard, M., Rohde, M., & Jäättelä, M. (2007) · FEBS Letters · doi:10.1016/j.febslet.2007.05.039 · Cited by 1,161 · see citing works

CD91 Is a Common Receptor for Heat Shock Proteins gp96, hsp90, hsp70, and Calreticulin

Basu, S., Binder, R. J., Ramalingam, T. R., & Srivastava, P. K. (2001) · Immunity · doi:10.1016/s1074-7613(01)00111-x · Cited by 1,123 · see citing works

Modulation of neurodegeneration by molecular chaperones

Muchowski, P. J., & Wacker, J. L. (2004) · Nature reviews. Neuroscience · doi:10.1038/nrn1587 · Cited by 1,021 · see citing works

A Cross-Sectional Study

Drozdzowska, B., Pluskiewicz, W., Halaba, Z. P., Misiołek, H., & Beck, B. R. (2005) · Cited by 984 · see citing works

Proteotoxic stress and inducible chaperone networks in neurodegenerative disease and aging

Morimoto, R. I. (2008) · Genes & Development · doi:10.1101/gad.1657108 · Cited by 872 · see citing works

Overexpression of the rat inducible 70-kD heat stress protein in a transgenic mouse increases the resistance of the heart to ischemic injury.

Marber, M. S., Mestril, R., H, S., Sayen, M. R., Yellon, D. M., & DILLMANN, W. H. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117815 · Cited by 843 · see citing works

Niemann-Pick disease type C1 is a sphingosine storage disease that causes deregulation of lysosomal calcium

Lloyd‐Evans, E., Morgan, A. J., He, X., Smith, D. A., Elliot-Smith, E., Sillence, D. J., Churchill, G. C., Schuchman, E. H., Galione, A., & Platt, F. M. (2008) · Nature Medicine · doi:10.1038/nm.1876 · Cited by 832 · see citing works

Approaches to transport therapeutic drugs across the blood–brain barrier to treat brain diseases

Gabathuler, R. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.07.028 · Cited by 804 · see citing works

Murine Model of Niemann-Pick C Disease: Mutation in a Cholesterol Homeostasis Gene

Loftus, S. K., Morris, J. A., Carstea, E. D., Gu, J. Z., Cummings, C., Brown, A., Ellison, J., Ohno, K., Rosenfeld, M. A., Tagle, D. A., et al. (1997) · Science · doi:10.1126/science.277.5323.232 · Cited by 798 · see citing works

Regulation of H SF 1 Function in the Heat Stress Response: Implications in Aging and Disease

Anckar, J., & Sistonen, L. (2011) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-060809-095203 · Cited by 779 · see citing works

Lysosomes in cell death

Guicciardi, M. E., Leist, M., & Gores, G. J. (2004) · Oncogene · doi:10.1038/sj.onc.1207512 · Cited by 716 · see citing works

Chaperoning signaling pathways: molecular chaperones as stress-sensing`heat shock' proteins

Nollen, E. A. A., & Morimoto, R. I. (2002) · Journal of Cell Science · doi:10.1242/jcs.115.14.2809 · Cited by 644 · see citing works

Involvement of the low‐density lipoprotein receptor‐related protein in the transcytosis of the brain delivery vector Angiopep‐2

Demeule, M., Currie, J., Bertrand, Y., Ché, C., Nguyen, T., Régina, A., Gabathuler, R., Castaigne, J., & Béliveau, R. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05492.x · Cited by 557 · see citing works

Transgenic mice expressing the human heat shock protein 70 have improved post-ischemic myocardial recovery.

Plumier, J.-C., Ross, B. M., Currie, R. W., Angelidis, C., kazlaris, H., Kollias, G. A., & Pagoulatos, G. N. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117865 · Cited by 553 · see citing works

Heat Shock Protein 70 Promotes Cell Survival by Inhibiting Lysosomal Membrane Permeabilization

Nylandsted, J., Gyrd-Hansen, M., Danielewicz, A., Fehrenbacher, N., Lademann, U., Høyer-Hansen, M., Weber, E., Multhoff, G., Rohde, M., & Jäättelä, M. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040531 · Cited by 545 · see citing works

Treatment with arimoclomol, a coinducer of heat shock proteins, delays disease progression in ALS mice

Kieran, D., Kalmár, B., Dick, J. R. T., Riddoch‐Contreras, J., Burnstock, G., & Greensmith, L. (2004) · Nature Medicine · doi:10.1038/nm1021 · Cited by 522 · see citing works

Hsp70 stabilizes lysosomes and reverts Niemann–Pick disease-associated lysosomal pathology

Kirkegaard, T., Roth, A. G., Petersen, N. H. T., Mahalka, A. K., Olsen, O. D., Moilanen, I., Zylicz, A., Knudsen, J., Sandhoff, K., Arenz, C., et al. (2010) · Nature · doi:10.1038/nature08710 · Cited by 519 · see citing works

Protein Quality Control in the Cytosol and the Endoplasmic Reticulum: Brothers in Arms

Buchberger, A., Bukau, B., & Sommer, T. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.10.001 · Cited by 483 · see citing works

Heat shock proteins as cellular lifeguards

Jäättelä, M. (1999) · Annals of Medicine · doi:10.3109/07853899908995889 · Cited by 482 · see citing works

Mouse models of Tay–Sachs and Sandhoff diseases differ in neurologic phenotype and ganglioside metabolism

Sango, K., Yamanaka, S., Hoffmann, A., Okuda, Y., Grinberg, A., Westphal, H., McDonald, M. P., Crawley, J. N., Sandhoff, K., Suzuki, K., et al. (1995) · Nature Genetics · doi:10.1038/ng1095-170 · Cited by 468 · see citing works

PRINCIPLES OF LYSOSOMAL MEMBRANE DIGESTION: Stimulation of Sphingolipid Degradation by Sphingolipid Activator Proteins and Anionic Lysosomal Lipids

Kolter, T., & Sandhoff, K. (2005) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.21.122303.120013 · Cited by 464 · see citing works

Capillary Depletion Method for Quantification of Blood–Brain Barrier Transport of Circulating Peptides and Plasma Proteins

Triguero, D., Buciak, J. L., & Pardridge, W. M. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb04886.x · Cited by 454 · see citing works

Chronic Cyclodextrin Treatment of Murine Niemann-Pick C Disease Ameliorates Neuronal Cholesterol and Glycosphingolipid Storage and Disease Progression

Davidson, C. D., Ali, N. F., Micsenyi, M. C., Stephney, G. W., Renault, S., Dobrenis, K., Ory, D. S., Vanier, M. T., & Walkley, S. U. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006951 · Cited by 449 · see citing works

The Heat Shock Response: Systems Biology of Proteotoxic Stress in Aging and DiseasePreprint

Morimoto, R. (2011) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2012.76.010637 · Cited by 407 · see citing works

Lysosomal storage diseases: from pathophysiology to therapy

Parenti, G., Andria, G., & Ballabio, A. (2015) · Annual Review of Medicine · doi:10.1146/annurev-med-122313-085916 · Cited by 404 · see citing works

Lysosomal involvement in cell death and cancer

Kirkegaard, T., & Jäättelä, M. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2008.09.008 · Cited by 395 · see citing works

α-Galactosidase A deficient mice: A model of Fabry disease

Ohshima, T., Murray, G. J., Swaim, W. D., Longenecker, G., Quirk, J. M., CARDARELLI, C. O., Sugimoto, Y., Pastan, I. H., Gottesman, M. M., Brady, R. O., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.6.2540 · Cited by 366 · see citing works

Chemical and Biological Approaches Synergize to Ameliorate Protein-Folding Diseases

Mu, T., Ong, D. S. T., Wang, Y., Balch, W. E., Yates, J. R., Segatori, L., & Kelly, J. W. (2008) · Cell · doi:10.1016/j.cell.2008.06.037 · Cited by 359 · see citing works

CD40, an extracellular receptor for binding and uptake of Hsp70–peptide complexes

Becker, T., Hartl, F. U., & Wieland, F. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200208083 · Cited by 356 · see citing works

Transformation-Associated Changes in Sphingolipid Metabolism Sensitize Cells to Lysosomal Cell Death Induced by Inhibitors of Acid Sphingomyelinase

Petersen, N. H. T., Olsen, O. D., Groth‐Pedersen, L., Ellegaard, A., Bilgin, M., Redmer, S., Ostenfeld, M. S., Ulanet, D., Dovmark, T. H., Lønborg, A., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.08.003 · Cited by 335 · see citing works

Critical role for glycosphingolipids in Niemann-Pick disease type C

Zervas, M., Somers, K. L., Thrall, M. A., & Walkley, S. U. (2001) · Current Biology · doi:10.1016/s0960-9822(01)00396-7 · Cited by 324 · see citing works

Sphingolipid lysosomal storage disorders

Platt, F. M. (2014) · Nature · doi:10.1038/nature13476 · Cited by 320 · see citing works

Heat shock transcription factor 1 as a therapeutic target in neurodegenerative diseases

Neef, D. W., Jaeger, A. M., & Thiele, D. J. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3453 · Cited by 307 · see citing works

GM1-Ganglioside Accumulation at the Mitochondria-Associated ER Membranes Links ER Stress to Ca2+-Dependent Mitochondrial Apoptosis

Sano, R., Annunziata, I., Patterson, A. E., Moshiach, S., Gomero, E. M., Opferman, J. T., Forte, M. A., & d’Azzo, A. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.10.021 · Cited by 288 · see citing works

Bimoclomol: A nontoxic, hydroxylamine derivative with stress protein-inducing activity and cytoprotective effects

Vígh, L., Literáti, P. N., Horváth, I., Török, Z., Balogh, G. E., Glatz, A., Kovács, E., Boros, I., Ferdinándy, P., Parkas, B., et al. (1997) · Nature Medicine · doi:10.1038/nm1097-1150 · Cited by 278 · see citing works

Hsp72 preserves muscle function and slows progression of severe muscular dystrophy

Gehrig, S. M., van der Poel, C., Sayer, T. A., Schertzer, J. D., Henstridge, D. C., Church, J. E., Lamon, S., Russell, A. P., Davies, K. E., Febbraio, M. A., et al. (2012) · Nature · doi:10.1038/nature10980 · Cited by 274 · see citing works

Delayed symptom onset and increased life expectancy in Sandhoff disease mice treated with N -butyldeoxynojirimycin

Jeyakumar, M., Butters, T. D., Cortina‐Borja, M., Hunnam, V., Proia, R. L., Perry, V. H., Dwek, R. A., & Platt, F. M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.11.6388 · Cited by 267 · see citing works

The role of glycosphingolipid metabolism in the developing brain

Yu, R. K., Nakatani, Y., & Yanagisawa, M. (2008) · Journal of Lipid Research · doi:10.1194/jlr.r800028-jlr200 · Cited by 267 · see citing works

Dramatically Different Phenotypes in Mouse Models of Human Tay-Sachs and Sandhoff Diseases

Phaneuf, D., Wakamatsu, N., Huang, J., Borowski, A., Peterson, A. C., Fortunato, S. R., Ritter, G., Igdoura, S. A., Morales, C. R., Benoit, G., et al. (1996) · Human Molecular Genetics · doi:10.1093/hmg/5.1.1 · Cited by 257 · see citing works

GM1-Ganglioside-Mediated Activation of the Unfolded Protein Response Causes Neuronal Death in a Neurodegenerative Gangliosidosis

Tessitore, A., Martin, M. D. P., Sano, R., Ma, Y., Männ, L., Ingrassia, A. M. T., Laywell, E. D., Steindler, D. A., Hendershot, L. M., & d’Azzo, A. (2004) · Molecular Cell · doi:10.1016/j.molcel.2004.08.029 · Cited by 226 · see citing works

Lysobisphosphatidic Acid Controls Endosomal Cholesterol Levels

Chevallier, J., Chamoun, Z., Jiang, G., Prestwich, G. D., Sakai, N., Matile, S., Parton, R. G., & Gruenberg, J. E. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m801463200 · Cited by 220 · see citing works

Secondary lipid accumulation in lysosomal disease

Walkley, S. U., & Vanier, M. T. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2008.11.014 · Cited by 218 · see citing works

Fabry Disease: Preclinical Studies Demonstrate the Effectiveness of α-Galactosidase A Replacement in Enzyme-Deficient Mice

Ioannou, Y. A., Zeidner, K. M., Gordon, R. E., & Desnick, R. J. (2001) · The American Journal of Human Genetics · doi:10.1086/316953 · Cited by 199 · see citing works

Lipids on Trial: The Search for the Offending Metabolite in Niemann-Pick type C Disease

Lloyd‐Evans, E., & Platt, F. M. (2010) · Traffic · doi:10.1111/j.1600-0854.2010.01032.x · Cited by 199 · see citing works

Lipid Changes in Niemann-Pick Disease Type C Brain: Personal Experience and Review of the Literature

Vanier, M. T. (1999) · Neurochemical Research · doi:10.1023/a:1022575511354 · Cited by 195 · see citing works

Interaction of Heat Shock Protein 70 Peptide with NK Cells Involves the NK Receptor CD94

Groß, C. C., Hansch, D., Gastpar, R., & Multhoff, G. (2003) · Biological Chemistry · doi:10.1515/bc.2003.030 · Cited by 194 · see citing works

Histone deacetylase inhibitor treatment dramatically reduces cholesterol accumulation in Niemann-Pick type C1 mutant human fibroblasts

Pipalia, N. H., Cosner, C. C., Huang, A. Y., Chatterjee, A., Bourbon, P., Farley, N., Helquist, P. M., Wiest, O., & Maxfield, F. R. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1014890108 · Cited by 186 · see citing works

A genetic storage disorder in BALB/C mice with a metabolic block in esterification of exogenous cholesterol.

Pentchev, P. G., Boothe, A. D., Kruth, H. S., Weintroub, H., Stivers, J. A., & Brady, R. O. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)91082-3 · Cited by 184 · see citing works

Tumor necrosis factor-α-associated lysosomal permeabilization is cathepsin B dependent

Werneburg, N. W., Guicciardi, M. E., Bronk, S. F., & Gores, G. J. (2002) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00151.2002 · Cited by 179 · see citing works

Analysis of fluorescently labeled glycosphingolipid-derived oligosaccharides following ceramide glycanase digestion and anthranilic acid labeling

Neville, D. C. A., Coquard, V., Priestman, D. A., Vruchte, D. T., Sillence, D. J., Dwek, R. A., Platt, F. M., & Butters, T. D. (2004) · Analytical Biochemistry · doi:10.1016/j.ab.2004.03.051 · Cited by 178 · see citing works

Niemann-Pick Type C1 I1061T Mutant Encodes a Functional Protein That Is Selected for Endoplasmic Reticulum-associated Degradation Due to Protein Misfolding

Gelsthorpe, M. E., Baumann, N. A., Millard, E. E., Gale, S. E., Langmade, S. J., Schaffer, J. E., & Ory, D. S. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m708735200 · Cited by 169 · see citing works

Multi-system disorders of glycosphingolipid and ganglioside metabolism

Xu, Y.-H., Barnes, S., Sun, Y., & Grabowski, G. A. (2010) · Journal of Lipid Research · doi:10.1194/jlr.r003996 · Cited by 167 · see citing works

Late stage treatment with arimoclomol delays disease progression and prevents protein aggregation in the SOD1G93A mouse model of ALS

Kalmár, B., Novoselov, S. S., Gray, A. L., Cheetham, M. E., Margulis, B. A., & Greensmith, L. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05595.x · Cited by 166 · see citing works

Reduction of globotriaosylceramide in Fabry disease mice by substrate deprivation

Abe, A., Gregory, S., Lee, L., Killen, P. D., Brady, R. O., Kulkarni, A. B., & Shayman, J. A. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9711 · Cited by 161 · see citing works

Anti-cancer agent siramesine is a lysosomotropic detergent that induces cytoprotective autophagosome accumulation

Ostenfeld, M. S., Høyer-Hansen, M. H., Bastholm, L., Fehrenbacher, N., Olsen, O. D., Groth‐Pedersen, L., Puustinen, P., Kirkegaard‐Sørensen, T., Nylandsted, J., Farkas, T., et al. (2008) · Autophagy · doi:10.4161/auto.5774 · Cited by 160 · see citing works

Lysosomal Degradation on Vesicular Membrane Surfaces

Wilkening, G., Linke, T. A., & Sandhoff, K. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.46.30271 · Cited by 155 · see citing works

Implications for invariant natural killer T cell ligands due to the restricted presence of isoglobotrihexosylceramide in mammals

Speak, A. O., Salio, M., Neville, D. C. A., Fontaine, J., Priestman, D. A., Platt, N., Heare, T., Butters, T. D., Dwek, R. A., Trottein, F., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607285104 · Cited by 152 · see citing works

Brain gangliosides in axon–myelin stability and axon regeneration

Schnaar, R. L. (2009) · FEBS Letters · doi:10.1016/j.febslet.2009.10.011 · Cited by 152 · see citing works

Niemann-Pick disease type C symptomatology: an expert-based clinical description

Mengel, E., Klünemann, H.-H., Lourenço, C. M., Hendriksz, C. J., Sedel, F., Walterfang, M., & Kolb, S. (2013) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-8-166 · Cited by 151 · see citing works

Exogenous Delivery of Heat Shock Protein 70 Increases Lifespan in a Mouse Model of Amyotrophic Lateral Sclerosis

Gifondorwa, D. J., Robinson, M., Hayes, C. D., Taylor, A. R., Prevette, D. M., Oppenheim, R. W., Caress, J. B., & Milligan, C. E. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.4057-07.2007 · Cited by 134 · see citing works

Targeting protein homeostasis in sporadic inclusion body myositis

Ahmed, M., Machado, P., Miller, A., Spicer, C., Herbelin, L. L., He, J., Noel, J., Wang, Y., McVey, A., Pasnoor, M., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aad4583 · Cited by 131 · see citing works

The role of heat shock proteins in Amyotrophic Lateral Sclerosis: The therapeutic potential of Arimoclomol

Kalmár, B., Lu, C., & Greensmith, L. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.08.003 · Cited by 130 · see citing works

Implications for Therapy

Pandrea, I. V., & LANDAY, A. L. (2011) · Elsevier eBooks · doi:10.1016/b978-0-12-387715-4.00003-4 · Cited by 127 · see citing works

Interfacial Regulation of Acid Ceramidase Activity

Linke, T. A., Wilkening, G., Sadeghlar, F., Mozcall, H., Bernardo, K., Schuchman, E. H., & Sandhoff, K. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m006846200 · Cited by 126 · see citing works

A Murine Niemann-Pick C1 I1061T Knock-In Model Recapitulates the Pathological Features of the Most Prevalent Human Disease Allele

Praggastis, M., Tortelli, B. A., Zhang, J., Fujiwara, H., Sidhu, R., Chacko, A., Chen, Z., Chung, C., Lieberman, A. P., Sikora, J., et al. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.4173-14.2015 · Cited by 121 · see citing works

Stimulation of Acid Sphingomyelinase Activity by Lysosomal Lipids and Sphingolipid Activator Proteins

Linke, T. A., Wilkening, G., Lansmann, S., Moczall, H., Bartelsen, O., Weisgerber, J., & Sandhoff, K. (2001) · Biological Chemistry · doi:10.1515/bc.2001.035 · Cited by 118 · see citing works

Biomarkers in the diagnosis of lysosomal storage disorders: proteins, lipids, and inhibodies

Aerts, J. M. F. G., Kallemeijn, W. W., Wegdam, W., Ferraz, M. J., van Breemen, M. J., Dekker, N., Kramer, G., Poorthuis, B. J. H. M., Groener, J. E. M., Cox‐Brinkman, J., et al. (2011) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-011-9308-6 · Cited by 118 · see citing works

Arimoclomol at dosages up to 300 mg/day is well tolerated and safe in amyotrophic lateral sclerosis

Cudkowicz, M., Shefner, J. M., Simpson, E., Grasso, D., Yu, H., Zhang, H., Shui, A. M., Schoenfeld, D., Brown, R. H., Wieland, S., et al. (2008) · Muscle & Nerve · doi:10.1002/mus.21059 · Cited by 110 · see citing works

White and gray matter alterations in adults with Niemann-Pick disease type C

Walterfang, M., Fahey, M. C., Desmond, P. M., WOOD, A. G., Seal, M. L., Steward, C. E., Adamson, C. L., Kokkinos, C., Fietz, M., & Velakoulis, D. (2010) · Neurology · doi:10.1212/wnl.0b013e3181e6210e · Cited by 106 · see citing works

Accumulation of cholera toxin and GM1 ganglioside in the early endosome of Niemann–Pick C1-deficient cells

Sugimoto, Y., Ninomiya, H., Ohsaki, Y., Higaki, K., Davies, J. P., Ioannou, Y. A., & Ohno, K. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.221181998 · Cited by 105 · see citing works

Npc1 Acting in Neurons and Glia Is Essential for the Formation and Maintenance of CNS Myelin

Yu, T., & Lieberman, A. P. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003462 · Cited by 102 · see citing works

Toward the prediction of CNS drug-effect profiles in physiological and pathological conditions using microdialysis and mechanism-based pharmacokinetic-pharmacodynamic modeling

de Lange, E. C. M., Ravenstijn, P. G. M., Groenendaal, D., & van Steeg, T. J. (2005) · The AAPS Journal · doi:10.1208/aapsj070354 · Cited by 94 · see citing works

Miglustat Improves Purkinje Cell Survival and Alters Microglial Phenotype in Feline Niemann-Pick Disease Type C

Stein, V. M., Crooks, A. V., Ding, W., Prociuk, M. L., O’Donnell, P., Bryan, C., Sikora, T. U., Dingemanse, J., Vanier, M. T., Walkley, S. U., et al. (2012) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31825414a6 · Cited by 94 · see citing works

Degradation of Membrane-bound Ganglioside GM1

Wilkening, G., Linke, T. A., Uhlhorn-Dierks, G., & Sandhoff, K. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m006568200 · Cited by 93 · see citing works

Beneficial effects of substrate reduction therapy in a mouse model of GM1 gangliosidosis

Elliot-Smith, E., Speak, A. O., Lloyd‐Evans, E., Smith, D. A., van der Spoel, A. C., Jeyakumar, M., Butters, T. D., Dwek, R. A., d’Azzo, A., & Platt, F. M. (2008) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2008.02.005 · Cited by 84 · see citing works

Relative acidic compartment volume as a lysosomal storage disorder–associated biomarker

Vruchte, D. T., Speak, A. O., Wallom, K., Eisa, N. A., Smith, D. A., Hendriksz, C. J., Simmons, L., Lachmann, R., Cousins, A., Hartung, R., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci72835 · Cited by 82 · see citing works

Improvement in Lipid and Protein Trafficking in Niemann-Pick C1 Cells by Correction of a Secondary Enzyme Defect

Devlin, C. M., Pipalia, N. H., Liao, X., Schuchman, E. H., Maxfield, F. R., & Tabas, I. A. (2010) · Traffic · doi:10.1111/j.1600-0854.2010.01046.x · Cited by 81 · see citing works

Perturbed Myelination Process of Premyelinating Oligodendrocyte in Niemann‐PickType C Mouse

Takikita, S., Fukuda, T., Mohri, I., Yagi, T., & Suzuki, K. (2004) · Journal of Neuropathology and Experimental Neurology · doi:10.1093/jnen/63.6.660 · Cited by 77 · see citing works

Histone deacetylase inhibitors increase glucocerebrosidase activity in Gaucher disease by modulation of molecular chaperones

Yang, C., Rahimpour, S., Lu, J., Pacák, K., Ikejiri, B. L., Brady, R. O., & Zhuang, Z. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1221046110 · Cited by 75 · see citing works

Saposin A Mobilizes Lipids from Low Cholesterol and High Bis(monoacylglycerol)phosphate-containing Membranes

Locatelli‐Hoops, S., Remmel, N., Klingenstein, R., Breiden, B., Rossocha, M., Schoeniger, M., Koenigs, C., Saenger, W., & Sandhoff, K. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m607281200 · Cited by 73 · see citing works

Activation of the heat shock response in a primary cellular model of motoneuron neurodegeneration-evidence for neuroprotective and neurotoxic effects

Kalmár, B., & Greensmith, L. (2009) · Cellular & Molecular Biology Letters · doi:10.2478/s11658-009-0002-8 · Cited by 69 · see citing works

Endoplasmic Reticulum-associated Degradation of Niemann-Pick C1

Nakasone, N., Nakamura, Y. S., Higaki, K., Oumi, N., Ohno, K., & Ninomiya, H. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.549915 · Cited by 65 · see citing works

Co-induction of the heat shock response ameliorates disease progression in a mouse model of human spinal and bulbar muscular atrophy: implications for therapy

Malik, B. A., Nirmalananthan, N., Gray, A. L., Spada, A. R. L., Hanna, M. G., & Greensmith, L. (2013) · Brain · doi:10.1093/brain/aws343 · Cited by 65 · see citing works

Upregulation of Heat Shock Proteins Rescues Motoneurones from Axotomy-Induced Cell Death in Neonatal Rats

Kalmár, B., Burnstock, G., Vrbovà, G., Urbanics, R., Csermely, P., & Greensmith, L. (2002) · Experimental Neurology · doi:10.1006/exnr.2002.7945 · Cited by 65 · see citing works

Hydroximic Acid Derivatives: Pleiotropic Hsp Co-Inducers Restoring Homeostasis and Robustness

Crul, T., Tóth, N., Piotto, S., Literati-Nagy, P., Tory, K., Haldimann, P., Kalmár, B., Greensmith, L., Török, Z., Balogh, G. E., et al. (2012) · Current Pharmaceutical Design · doi:10.2174/138161213804143716 · Cited by 64 · see citing works

Iminosugar-based inhibitors of glucosylceramide synthase prolong survival but paradoxically increase brain glucosylceramide levels in Niemann–Pick C mice

Nietupski, J. B., Pacheco, J., Chuang, W., Maratea, K. A., Li, L., Foley, J., Ashe, K. M., Cooper, C. G. F., Aerts, J. M. F. G., Copeland, D., et al. (2012) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2012.01.020 · Cited by 64 · see citing works

The heat-shock response co-inducer arimoclomol protects against retinal degeneration in rhodopsin retinitis pigmentosa

Parfitt, D. A., Aguilà, M., McCulley, C. H., Bevilacqua, D., Mendes, H. F., Athanasiou, D., Novoselov, S. S., Kanuga, N., Munro, P., Coffey, P. J., et al. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.214 · Cited by 60 · see citing works

Lysosomal Membrane Permeability Stimulates Protein Aggregate Formation in Neurons of a Lysosomal Disease

Micsenyi, M. C., Sikora, J., Stephney, G. W., Dobrenis, K., & Walkley, S. U. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.0987-13.2013 · Cited by 56 · see citing works

Effect of sialoadenectomy and salivary gland extracts on gastrointestinal mucosal growth and gastrin levels in the rat.

Skinner, K. A., Soper, B. D., & Tepperman, B. L. (1984) · The Journal of Physiology · doi:10.1113/jphysiol.1984.sp015227 · Cited by 54 · see citing works

Arimoclomol: a potential therapy under development for ALS

Lanka, V., Wieland, S., Barber, J. R., & Cudkowicz, M. (2009) · Expert Opinion on Investigational Drugs · doi:10.1517/13543780903357486 · Cited by 53 · see citing works

Effect of BRX‐220 against Peripheral Neuropathy and Insulin Resistance in Diabetic Rat Models

Kurthy, M., MOGYORÓSI, T., NAGY, K., Kukorelli, T., Jednákovits, A., Tálosi, L., & BÍRÓ, K. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04306.x · Cited by 53 · see citing works

Human heat shock protein 70 (Hsp70) as a peripheral membrane protein

Mahalka, A. K., Kirkegaard, T., Jukola, L. T. I., Jäättelä, M., & Kinnunen, P. K. J. (2014) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2014.01.022 · Cited by 52 · see citing works

Brothers in arms.

Martini, C. D. (2008) · PubMed · Cited by 48 · see citing works

Size and Shape of the Corpus Callosum in Adult Niemann-Pick Type C Reflects State and Trait Illness Variables

Walterfang, M., Fahey, M. C., Abel, L. A., Fietz, M., WOOD, A. G., Bowman, E. A., Reutens, D. C., & Velakoulis, D. (2011) · American Journal of Neuroradiology · doi:10.3174/ajnr.a2490 · Cited by 47 · see citing works

Pontine‐to‐midbrain ratio indexes ocular‐motor function and illness stage in adult Niemann–Pick disease type C

Walterfang, M., Macfarlane, M. D., Looi, J. C., Abel, L. A., Bowman, E. A., Fahey, M. C., Desmond, P. M., & Velakoulis, D. (2012) · European Journal of Neurology · doi:10.1111/j.1468-1331.2011.03545.x · Cited by 46 · see citing works

Celastrol increases glucocerebrosidase activity in Gaucher disease by modulating molecular chaperones

Yang, C., Swallows, C. L., Zhang, C., Lu, J., Xiao, H., Brady, R. O., & Zhuang, Z. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1321341111 · Cited by 45 · see citing works

Lysosomal storage diseases and the heat shock response: convergences and therapeutic opportunities

Ingemann, L., & Kirkegaard, T. (2014) · Journal of Lipid Research · doi:10.1194/jlr.r048090 · Cited by 44 · see citing works

Heat Shock Protein 70.1 (Hsp70.1) Affects Neuronal Cell Fate by Regulating Lysosomal Acid Sphingomyelinase

Zhu, H., Yoshimoto, T., & Yamashima, T. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.560334 · Cited by 44 · see citing works

Studies on human liver alpha-galactosidases. II. Purification and enzymatic properties of alpha-galactosidase B (alpha-N-acetylgalactosaminidase).

Dean, K. J., & Sweeley, C. C. (1979) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)86664-4 · Cited by 43 · see citing works

Spontaneous Activation of Pancreas Trypsinogen in Heat Shock Protein 70.1 Knock-out Mice

Hwang, J., Ryu, J. K., Yoon, Y. B., Lee, K. H., Park, Y.-S., Kim, J., Kim, N., Lee, D. H., Jeong, J. B., Seo, J., et al. (2005) · Pancreas · doi:10.1097/01.mpa.0000183377.04295.c3 · Cited by 38 · see citing works

Animal models for metabolic, neuromuscular and ophthalmological rare diseases

Vaquer, G., Rivière, F., Mavris, M., Bignami, F., Llinares, J., Westermark, K., & Sepodes, B. M. N. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd3831 · Cited by 37 · see citing works

Emerging therapies and therapeutic concepts for lysosomal storage diseases

Kirkegaard, T. (2013) · Expert Opinion on Orphan Drugs · doi:10.1517/21678707.2013.780970 · Cited by 32 · see citing works

Decreased expression of myelin gene regulatory factor in Niemann-Pick type C 1 mouse

Yan, X., Lukáš, J., Witt, M., Wree, A., Hübner, R., Frech, M. J., Köhling, R., Rolfs, A., & Luo, J. (2011) · Metabolic Brain Disease · doi:10.1007/s11011-011-9263-9 · Cited by 31 · see citing works

Microdialysis Evaluation of Clozapine and N-Desmethylclozapine Pharmacokinetics in Rat Brain

Cremers, T. I. F. H., Flik, G., Hofland, C. M., & Stratford, R. E. (2012) · Drug Metabolism and Disposition · doi:10.1124/dmd.112.045682 · Cited by 29 · see citing works

HSP70 and lysosomal storage disorders: novel therapeutic opportunities

Petersen, N. H. T., & Kirkegaard, T. (2010) · Biochemical Society Transactions · doi:10.1042/bst0381479 · Cited by 27 · see citing works

The proteasome inhibitor bortezomib reduced cholesterol accumulation in fibroblasts from Niemann–Pick type C patients carrying missense mutations

Macías‐Vidal, J., Girós, M., Guerrero‐Hernández, M., Gascón, P., Serratosa, J., Bachs, O., & Coll, M. J. (2014) · FEBS Journal · doi:10.1111/febs.12954 · Cited by 26 · see citing works

Treatment of Human Fibroblasts Carrying NPC1 Missense Mutations with MG132 Leads to an Improvement of Intracellular Cholesterol Trafficking

Zampieri, S., Bembi, B., Rosso, N., Filocamo, M., & Dardis, A. (2011) · JIMD Reports · doi:10.1007/8904_2011_49 · Cited by 24 · see citing works

Pharmacokinetic and Tissue Distribution Mechanism of Mouse Recombinant Heat Shock Protein 70 in Mice

Takemoto, S., Nishikawa, M., & Takakura, Y. (2005) · Pharmaceutical Research · doi:10.1007/s11095-004-1880-0 · Cited by 24 · see citing works

The therapeutic potential of pharmacological chaperones and proteosomal inhibitors, Celastrol and MG132 in the treatment of sialidosis

O’Leary, E. M., & Igdoura, S. A. (2012) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2012.07.013 · Cited by 23 · see citing works

Treatment for familial amyotrophic lateral sclerosis/motor neuron disease

Benatar, M. G., Kurent, J. E., & Moore, D. H. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006153.pub2 · Cited by 9 · see citing works

Treatment for familial amyotrophic lateral sclerosis/motor neuron disease

Benatar, M. G., Kurent, J. E., & Moore, D. H. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006153 · Cited by 1 · see citing works

Proceedings of the Physiological Society, 24‐25 February 1984, Imperial College Meeting: Demonstrations

(1984) · The Journal of Physiology · doi:10.1113/jphysiol.1984.sp015272 · Cited by 1 · see citing works

Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018.

Galluzzi, L., Vitale, I., Aaronson, S. A., Abrams, J. M., Adam, D., Agostinis, P., Alnemri, E. S., Altucci, L., Amelio, I., Andrews, D. W., et al. (2018) · Cell Death & Differentiation · doi:10.1038/s41418-017-0012-4 · Cited by 6,680 · see citing works

Lysosomal storage diseases

Platt, F. M., d’Azzo, A., Davidson, B. L., Neufeld, E. F., & Tifft, C. J. (2018) · Nature Reviews Disease Primers · doi:10.1038/s41572-018-0025-4 · Cited by 1,052 · see citing works

LYSOSOMAL STORAGE DISEASES

Neufeld, E. F. (1991) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.60.070191.001353 · Cited by 924 · see citing works

Lysosomal membrane permeabilization and cell death

Wang, F., Gómez‐Sintes, R., & Boya, P. (2018) · Traffic · doi:10.1111/tra.12613 · Cited by 781 · see citing works

Tumor-educated B cells selectively promote breast cancer lymph node metastasis by HSPA4-targeting IgG

Gu, Y., Liu, Y., Fu, L., Zhai, L., Zhu, J., Han, Y., Jiang, Y., Zhang, Y., Zhang, P., Jiang, Z., et al. (2019) · Nature Medicine · doi:10.1038/s41591-018-0309-y · Cited by 267 · see citing works

Emptying the stores: lysosomal diseases and therapeutic strategies

Platt, F. M. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.214 · Cited by 249 · see citing works

The rapidly evolving view of lysosomal storage diseases

Parenti, G., Medina, D. L., & Ballabio, A. (2021) · EMBO Molecular Medicine · doi:10.15252/emmm.202012836 · Cited by 230 · see citing works

Amyloid assembly and disassembly

Chuang, E., Hori, A. M., Hesketh, C. D., & Shorter, J. (2018) · Journal of Cell Science · doi:10.1242/jcs.189928 · Cited by 182 · see citing works

Biophysical and Mechanistic Models for Disease-Causing Protein Variants

Stein, A., Fowler, D. M., Hartmann‐Petersen, R., & Lindorff‐Larsen, K. (2019) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2019.01.003 · Cited by 162 · see citing works

Lysosomal enzyme replacement therapies: Historical development, clinical outcomes, and future perspectives

Solomon, M. A., & Muro, S. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.05.004 · Cited by 159 · see citing works

Genetics and Therapies for GM2 Gangliosidosis

Cachón-González, M. B., Zaccariotto, E., & Cox, T. M. (2018) · Current Gene Therapy · doi:10.2174/1566523218666180404162622 · Cited by 135 · see citing works

Treatment strategies for lysosomal storage disorders

Beck, M. (2017) · Developmental Medicine & Child Neurology · doi:10.1111/dmcn.13600 · Cited by 114 · see citing works

Hsp70 interactions with membrane lipids regulate cellular functions in health and disease

Balogi, Z., Multhoff, G., Jensen, T. K., Lloyd‐Evans, E., Yamashima, T., Jäättelä, M., Harwood, J. L., & Vı́gh, L. (2019) · Progress in Lipid Research · doi:10.1016/j.plipres.2019.01.004 · Cited by 112 · see citing works

Heat Shock Proteins and Autophagy Pathways in Neuroprotection: From Molecular Bases to Pharmacological Interventions

Penke, B., Bogár, F., Crul, T., Sántha, M., Tóth, M. E., & Vı́gh, L. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19010325 · Cited by 106 · see citing works

Niemann–Pick type C disease: cellular pathology and pharmacotherapy

Wheeler, S., & Sillence, D. J. (2019) · Journal of Neurochemistry · doi:10.1111/jnc.14895 · Cited by 107 · see citing works

Efficacy and safety of arimoclomol in Niemann‐Pick disease type C: Results from a double‐blind, randomised, placebo‐controlled, multinational phase 2/3 trial of a novel treatment

Mengel, K. E., Patterson, M. C., Riol, R. M. D., del Toro, M., Deodato, F., Gautschi, M., Grünewald, S., Grønborg, S. W., Harmatz, P., Héron, B., et al. (2021) · Journal of Inherited Metabolic Disease · doi:10.1002/jimd.12428 · Cited by 103 · see citing works

Navigating the landscape of protein folding and proteostasis: from molecular chaperones to therapeutic innovations

Kuzu, O., Granerud, L. J. T., & Saatcioglu, F. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02439-w · Cited by 107 · see citing works

Membrane-lipid therapy: A historical perspective of membrane-targeted therapies — From lipid bilayer structure to the pathophysiological regulation of cells

Escribá, P. V. (2017) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2017.05.017 · Cited by 96 · see citing works

Inclusion Body Myositis: Update on Pathogenesis and Treatment

Naddaf, E., Barohn, R. J., & Dimachkie, M. M. (2018) · Neurotherapeutics · doi:10.1007/s13311-018-0658-8 · Cited by 89 · see citing works

Acetyl-leucine slows disease progression in lysosomal storage disorders

Kaya, E., Smith, D. A., Smith, C., Morris, L., Brémovà-Ertl, T., Cortina‐Borja, M., Fineran, P., Morten, K., Poulton, J., Boland, B., et al. (2020) · Brain Communications · doi:10.1093/braincomms/fcaa148 · Cited by 86 · see citing works

A Human Stem Cell Model of Fabry Disease Implicates LIMP-2 Accumulation in Cardiomyocyte Pathology

Birket, M. J., Raibaud, S., Lettieri, M., Adamson, A. D., Letang, V., Cervello, P., Redon, N., Ret, G., Viale, S., Wang, B., et al. (2019) · Stem Cell Reports · doi:10.1016/j.stemcr.2019.07.004 · Cited by 80 · see citing works

Role of a Heat Shock Transcription Factor and the Major Heat Shock Protein Hsp70 in Memory Formation and Neuroprotection

Zatsepina, O. G., Evgen’ev, M. B., & Garbuz, D. G. (2021) · Cells · doi:10.3390/cells10071638 · Cited by 79 · see citing works

Annual severity increment score as a tool for stratifying patients with Niemann-Pick disease type C and for recruitment to clinical trials

Cortina‐Borja, M., Vruchte, D. T., Mengel, E., Amraoui, Y., Imrie, J., Jones, S. A., Dali, C. Í., Fineran, P., Kirkegaard, T., Runz, H., et al. (2018) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-018-0880-9 · Cited by 72 · see citing works

NPC1 enables cholesterol mobilization during long‐term potentiation that can be restored in Niemann–Pick disease type C by CYP46A1 activation

Mitroi, D. N., Pereyra, G., Soto‐Huelin, B., Senovilla, F., Kobayashi, T., Esteban, J. A., & Ledesma, M. D. (2019) · EMBO Reports · doi:10.15252/embr.201948143 · Cited by 69 · see citing works

Graphene oxide / BaHoF5 / PEG nanocomposite for dual-modal imaging and heat shock protein inhibitor-sensitized tumor photothermal therapy

Xu, C., Zhang, M., Wang, C., Zhang, J., Wu, H., & Yang, S. (2019) · Carbon · doi:10.1016/j.carbon.2019.10.105 · Cited by 69 · see citing works

Understanding the phenotypic variability in Niemann-Pick disease type C (NPC): a need for precision medicine

Heras, M. L., Szenfeld, B., Ballout, R. A., Buratti, E., Zanlungo, S., Dardis, A., & Klein, A. D. (2023) · npj Genomic Medicine · doi:10.1038/s41525-023-00365-w · Cited by 67 · see citing works

Lysosomal functions and dysfunctions: Molecular and cellular mechanisms underlying Gaucher disease and its association with Parkinson disease

Horowitz, M., Braunstein, H., Zimran, A., Revel‐Vilk, S., & Göker-Alpan, Ö. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114402 · Cited by 63 · see citing works

Insight into the Role of Extracellular Vesicles in Lysosomal Storage Disorders

Tancini, B., Buratta, S., Sagini, K., Costanzi, E., Delo, F., Urbanelli, L., & Emiliani, C. (2019) · Genes · doi:10.3390/genes10070510 · Cited by 54 · see citing works

The interaction of heat shock proteins with cellular membranes: a historical perspective

Maio, A. D., & Hightower, L. E. (2021) · Cell Stress and Chaperones · doi:10.1007/s12192-021-01228-y · Cited by 53 · see citing works

Gaucher disease – more than just a rare lipid storage disease

Roh, J., Subramanian, S., Weinreb, N. J., & Kartha, R. V. (2022) · Journal of Molecular Medicine · doi:10.1007/s00109-021-02174-z · Cited by 53 · see citing works

The Niemann-Pick type diseases – A synopsis of inborn errors in sphingolipid and cholesterol metabolism

Pfrieger, F. W. (2023) · Progress in Lipid Research · doi:10.1016/j.plipres.2023.101225 · Cited by 51 · see citing works

Evaluation of age of death in Niemann-Pick disease, type C: Utility of disease support group websites to understand natural history

Bianconi, S. E., Hammond, D., Farhat, N. Y., Do, A. N. D., Jenkins, K., Cougnoux, A., Martin, K. B., & Porter, F. D. (2019) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2019.02.004 · Cited by 51 · see citing works

The heat shock protein amplifier arimoclomol improves refolding, maturation and lysosomal activity of glucocerebrosidase

Fog, C. K., Zago, P., Malini, E., Solanko, L. M., Peruzzo, P., Bornæs, C., Magnoni, R., Mehmedbašić, A., Petersen, N. H. T., Bembi, B., et al. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2018.11.037 · Cited by 50 · see citing works

Clinical and Molecular Features of Early Infantile Niemann Pick Type C Disease

Yılmaz, B. Ş., Baruteau, J., Rahim, A. A., & Gissen, P. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21145059 · Cited by 48 · see citing works

Protein stability and degradation in health and disease

Clausen, L., Abildgaard, A. B., Gersing, S. K., Stein, A., Lindorff‐Larsen, K., & Hartmann‐Petersen, R. (2018) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2018.09.002 · Cited by 51 · see citing works

Molecular Mechanisms Underlying Neuroprotective Effect of Intranasal Administration of Human Hsp70 in Mouse Model of Alzheimer’s Disease

Evgen’ev, M. B., Krasnov, G. S., Nesterova, I. V., Garbuz, D. G., Карпов, В. Л., Morozov, A. V., Snezhkina, A. V., Samokhin, A. N., Sergeev, A., Куликов, А. М., et al. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170398 · Cited by 45 · see citing works

Drug‐induced increase in lysobisphosphatidic acid reduces the cholesterol overload in Niemann–Pick type C cells and mice

Moreau, D., Vacca, F., Vossio, S., Scott, C. C., Colaço, A., Montoya, J. P., Ferguson, C., Daμμe, M., Moniatte, M., Parton, R. G., et al. (2019) · EMBO Reports · doi:10.15252/embr.201847055 · Cited by 44 · see citing works

Targeting Cancer Lysosomes with Good Old Cationic Amphiphilic Drugs

Ellegaard, A., Bach, P. B., & Jäättelä, M. (2020) · Reviews of physiology, biochemistry and pharmacology · doi:10.1007/112_2020_56 · Cited by 44 · see citing works

Closest horizons of Hsp70 engagement to manage neurodegeneration

Venediktov, A. A., Bushueva, O. Y., Kudryavtseva, V. A., Kuzmin, E. A., Moiseeva, A. V., Baldycheva, A. V., Meglinski, I. V., & Piavchenko, G. A. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1230436 · Cited by 43 · see citing works

Osteoarthritis: molecular pathogenesis and potential therapeutic options

Zhang, Y., Han, Y.-Q., Sun, Y., Hao, L.-H., Gao, Y., Ye, J., Wang, H.-L., Zhang, T.-T., Liu, Y.-L., & Yang, Y.-F. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02556-6 · Cited by 24 · see citing works

Control of mitosis, inflammation, and cell motility by limited leakage of lysosomes

Stahl-Meyer, J., Stahl-Meyer, K., & Jäättelä, M. (2021) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2021.02.003 · Cited by 40 · see citing works

The CD22-IGF2R interaction is a therapeutic target for microglial lysosome dysfunction in Niemann-Pick type C

Pluvinage, J. V., Sun, J., Claes, C., Flynn, R. A., Haney, M. S., Iram, T., Meng, X., Lindemann, R. C., Riley, N. M., Danhash, E., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abg2919 · Cited by 40 · see citing works

Fabry disease: Mechanism and therapeutics strategies

Li, X., Ren, X., Zhang, Y., Ding, L., Huo, M., & Li, Q. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1025740 · Cited by 43 · see citing works

Niemann-Pick Disease, Type C: Diagnosis, Management and Disease-Targeted Therapies in Development

Berry‐Kravis, E. (2021) · Seminars in Pediatric Neurology · doi:10.1016/j.spen.2021.100879 · Cited by 39 · see citing works

Brain-wide microglia replacement using a nonconditioning strategy ameliorates pathology in mouse models of neurological disorders

Chen, D., Wang, C., Chen, X., Li, J., Chen, S., Li, Y., Ma, F., Li, T., Zou, M., Li, X., et al. (2025) · Science Translational Medicine · doi:10.1126/scitranslmed.ads6111 · Cited by 38 · see citing works

Inherited disorders of lysosomal membrane transporters

Huizing, M., & Gahl, W. A. (2020) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2020.183336 · Cited by 39 · see citing works

Safety and efficacy of arimoclomol for inclusion body myositis: a multicentre, randomised, double-blind, placebo-controlled trial

Machado, P., McDermott, M., Blaettler, T., Sundgreen, C., Amato, A. A., Ciafaloni, E., Freimer, M. L., Gibson, S. B., Jones, S. M., Levine, T., et al. (2023) · The Lancet Neurology · doi:10.1016/s1474-4422(23)00275-2 · Cited by 38 · see citing works

Linear Cyclodextrin Polymer Prodrugs as Novel Therapeutics for Niemann-Pick Type C1 Disorder

Kulkarni, A., Caporali, P., Dolas, A., Johny, S., Goyal, S., Dragotto, J., Macone, A., Jayaraman, R., & Fiorenza, M. T. (2018) · Scientific Reports · doi:10.1038/s41598-018-27926-9 · Cited by 37 · see citing works

Stroke Recovery in Rats after 24‐Hour–Delayed Intramuscular Neurotrophin‐3 Infusion

Duricki, D. A., Drndarski, S., Bernanos, M., Wood, T., Bosch, K. D., Chen, Q., Shine, H. D., Simmons, C., Williams, S., McMahon, S. B., et al. (2018) · Annals of Neurology · doi:10.1002/ana.25386 · Cited by 36 · see citing works

Animal models for Niemann-Pick type C: implications for drug discovery & development

Fog, C. K., & Kirkegaard, T. (2019) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2019.1588882 · Cited by 36 · see citing works

Understanding and Treating Niemann–Pick Type C Disease: Models Matter

Pallottini, V., & Pfrieger, F. W. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21238979 · Cited by 34 · see citing works

High-content screen for modifiers of Niemann-Pick type C disease in patient cells

Pugach, E. K., Feltes, M., Kaufman, R. J., Ory, D. S., & Bang, A. G. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddy117 · Cited by 33 · see citing works

Genetic background modifies phenotypic severity and longevity in a mouse model of Niemann-Pick disease type C1

Rodriguez‐Gil, J. L., Watkins‐Chow, D. E., Baxter, L. L., Elliot, G., Harper, U. L., Wincovitch, S., Wedel, J. C., Incao, A. A., Huebecker, M., Boehm, F. J., et al. (2020) · Disease Models & Mechanisms · doi:10.1242/dmm.042614 · Cited by 33 · see citing works

The Effect of Human HSP70 Administration on a Mouse Model of Alzheimer’s Disease Strongly Depends on Transgenicity and Age

Evgen’ev, M. B., Bobkova, N. V., Krasnov, G. S., Garbuz, D. G., Funikov, S. Y., Kudryavtseva, A. V., Куликов, А. М., Samokhin, A. N., Maltsev, A. V., & Nesterova, I. V. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-180987 · Cited by 32 · see citing works

Induced pluripotent stem cell models of lysosomal storage disorders

Borger, D. K., McMahon, B., Lal, T. R. R., Serra-Vinardell, J., Aflaki, E., & Sidransky, E. (2017) · Disease Models & Mechanisms · doi:10.1242/dmm.029009 · Cited by 26 · see citing works

Finding pathogenic commonalities between Niemann-Pick type C and other lysosomal storage disorders: Opportunities for shared therapeutic interventions

Yañez, M. J., Marín, T., Balboa, E., Klein, A. D., Alvarez, A. R., & Zanlungo, S. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2020.165875 · Cited by 29 · see citing works

Niemann-Pick disease, type C and Roscoe Brady

Patterson, M. C., & Walkley, S. U. (2016) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2016.11.008 · Cited by 28 · see citing works

Addressing neurodegeneration in lysosomal storage disorders: Advances in Niemann Pick diseases

Toledano‐Zaragoza, A., & Ledesma, M. D. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.107851 · Cited by 28 · see citing works

Clinical disease progression and biomarkers in Niemann–Pick disease type C: a prospective cohort study

Mengel, K. E., Bembi, B., del Toro, M., Deodato, F., Gautschi, M., Grünewald, S., Grønborg, S. W., Héron, B., Maier, E. M., Roubertie, A., et al. (2020) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-020-01616-0 · Cited by 28 · see citing works

4-HNE induces proinflammatory cytokines of human retinal pigment epithelial cells by promoting extracellular efflux of HSP70

Yang, H., Hu, R., Sun, H., Chen, B., Li, X., & Chen, J.-B. (2019) · Experimental Eye Research · doi:10.1016/j.exer.2019.107792 · Cited by 27 · see citing works

Developments in evidence creation for treatments of inborn errors of metabolism

Stöckler‐Ipsiroglu, S., Potter, B. K., Yuskiv, N., Tingley, K., Patterson, M. C., & van Karnebeek, C. (2020) · Journal of Inherited Metabolic Disease · doi:10.1002/jimd.12315 · Cited by 26 · see citing works

Identification of cerebral spinal fluid protein biomarkers in Niemann-Pick disease, type C1

Campbell, K. S., Cawley, N. X., Luke, R., Scott, K. E. J., Johnson, N., Farhat, N. Y., Alexander, D. M., Wassif, C. A., Li, W., Cologna, S. M., et al. (2023) · Biomarker Research · doi:10.1186/s40364-023-00448-x · Cited by 27 · see citing works

Individualized management of genetic diversity in Niemann-Pick C1 through modulation of the Hsp70 chaperone system

Wang, C., Scott, S. M., Sun, S., Zhao, P., Hutt, D. M., Shao, H., Gestwicki, J. E., & Balch, W. E. (2019) · Human Molecular Genetics · doi:10.1093/hmg/ddz215 · Cited by 27 · see citing works

Pre-clinical Mouse Models of Neurodegenerative Lysosomal Storage Diseases

Favret, J., Weinstock, N. I., Feltri, M. L., & Shin, D. (2020) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.00057 · Cited by 26 · see citing works

Myelin Defects in Niemann–Pick Type C Disease: Mechanisms and Possible Therapeutic Perspectives

Bernardo, A., Nuccio, C. D., Visentin, S., Martire, A., Minghetti, L., Popoli, P., & Ferrante, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168858 · Cited by 26 · see citing works

2-Hydroxypropyl-β-cyclodextrin is the active component in a triple combination formulation for treatment of Niemann-Pick C1 disease

Davidson, J. W., Molitor, E. A., Moores, S., Gale, S. E., Subramanian, K., Jiang, X., Sidhu, R., Kell, P. J., Zhang, J., Fujiwara, H., et al. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2019.04.011 · Cited by 24 · see citing works

Proteostasis regulators modulate proteasomal activity and gene expression to attenuate multiple phenotypes in Fabry disease

Seemann, S., Ernst, M., Cimmaruta, C., Struckmann, S., Cozma, C., Koczan, D., Knospe, A., Haake, L. R., Citro, V., Bräuer, A. U., et al. (2020) · Biochemical Journal · doi:10.1042/bcj20190513 · Cited by 24 · see citing works

Investigating the Mechanism of Cyclodextrins in the Treatment of Niemann-Pick Disease Type C Using Crosslinked 2-Hydroxypropyl-β-cyclodextrin.

Carradori, D., Chen, H., Werner, B., Shah, A., Leonardi, C., Usuelli, M., Mezzenga, R., Platt, F., & Leroux, J. (2020) · Small · doi:10.1002/smll.202004735 · Cited by 19 · see citing works

Drug Repositioning for Fabry Disease: Acetylsalicylic Acid Potentiates the Stabilization of Lysosomal Alpha-Galactosidase by Pharmacological Chaperones

Monticelli, M., Liguori, L., Allocca, M., Bosso, A., Andreotti, G., Lukáš, J., Monti, M. C., Morretta, E., Cubellis, M. V., & Mele, B. H. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23095105 · Cited by 23 · see citing works

Transcriptome of HPβCD-treated Niemann-Pick disease type C1 cells highlights GPNMB as a biomarker for therapeutics

Rodriguez‐Gil, J. L., Baxter, L. L., Watkins‐Chow, D. E., Johnson, N. L., Davidson, C. D., Carlson, S. R., Incao, A. A., Program, N. C. S., Wallom, K., Farhat, N. Y., et al. (2021) · Human Molecular Genetics · doi:10.1093/hmg/ddab194 · Cited by 22 · see citing works

Amplifying the Heat Shock Response Ameliorates ALS and FTD Pathology in Mouse and Human Models

Ahmed, M., Spicer, C., Harley, J., Taylor, J. P., Hanna, M. G., Patani, R., & Greensmith, L. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03509-2 · Cited by 22 · see citing works

Recent neuroimaging, neurophysiological, and neuropathological advances for the understanding of NPC

Benussi, A., Cotelli, M. S., Padovani, A., & Borroni, B. (2018) · F1000Research · doi:10.12688/f1000research.12361.1 · Cited by 21 · see citing works

NPC1 Deficiency in Mice is Associated with Fetal Growth Restriction, Neonatal Lethality and Abnormal Lung Pathology

Rodriguez‐Gil, J. L., Watkins‐Chow, D. E., Baxter, L. L., Yokoyama, T., Zerfas, P. M., Starost, M. F., Gahl, W. A., Malicdan, M. C. V., Porter, F. D., Platt, F. M., et al. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm9010012 · Cited by 21 · see citing works

4-HNE Induces Apoptosis of Human Retinal Pigment Epithelial Cells by Modifying HSP70

Yang, L., Chen, H., Wang, J., Xia, T., Sun, H., Yuan, C., Liu, S., & Chen, J.-B. (2019) · Current Medical Science · doi:10.1007/s11596-019-2057-8 · Cited by 21 · see citing works

Correction of Niemann-Pick type C1 trafficking and activity with the histone deacetylase inhibitor valproic acid

Subramanian, K., Hutt, D. M., Scott, S. M., Gupta, V. R., Mao, S., & Balch, W. E. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.010524 · Cited by 21 · see citing works

PGRN deficiency exacerbates, whereas a brain penetrant PGRN derivative protects, GBA1 mutation-associated pathologies and diseases

Zhao, X., Lin, Y., Liou, B., Fu, W., Jian, J., Fannin, V., Zhang, W., Setchell, K. D. R., Grabowski, G. A., Sun, Y., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2210442120 · Cited by 20 · see citing works

The Role of Hsp70 in Adaptation to Adverse Conditions and Its Possible Medical Application

Evgen’ev, M. B., Onikienko, S. B., Chuvakova, L. N., Garbuz, D. G., & Zatsepina, O. G. (2023) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2802025 · Cited by 19 · see citing works

Niemann-Pick Disease Type C (NPDC) by Mutation of NPC1 and NPC2: Aberrant Lysosomal Cholesterol Trafficking and Oxidative Stress

Lee, D., & Hong, J. H. (2023) · Antioxidants · doi:10.3390/antiox12122021 · Cited by 19 · see citing works

Mutation-induced LZTR1 polymerization provokes cardiac pathology in recessive Noonan syndrome

Busley, A. V., Gutiérrez‐Gutiérrez, Ó., Hammer, E., Koitka, F., Mirzaiebadizi, A., Steinegger, M., Pape, C., Böhmer, L., Schroeder, H., Kleinsorge, M., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114448 · Cited by 19 · see citing works

Accumulation of alkyl-lysophosphatidylcholines in Niemann-Pick disease type C1

Mishra, S., Kell, P. J., Scherrer, D. E., Dietzen, D. J., Vite, C. H., Berry‐Kravis, E., Davidson, C. D., Cologna, S. M., Porter, F. D., Ory, D. S., et al. (2024) · Journal of Lipid Research · doi:10.1016/j.jlr.2024.100600 · Cited by 18 · see citing works

HSP70 induces liver X receptor pathway activation and cholesterol reduction in vitro and in vivo

Güngör, B., Vanharanta, L., Hölttä‐Vuori, M., Pirhonen, J., Petersen, N. H. T., Gramolelli, S., Ojala, P. M., Kirkegaard, T., & Ikonen, E. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.07.005 · Cited by 18 · see citing works

Recent Advances and Novel Treatments for Sphingolipidoses

Arenz, C. (2017) · Future Medicinal Chemistry · doi:10.4155/fmc-2017-0065 · Cited by 18 · see citing works

HSP90 inhibitors reduce cholesterol storage in Niemann-Pick type C1 mutant fibroblasts

Pipalia, N. H., Saad, S. Z., Subramanian, K., Cross, A. C., al-Motawa, A., Garg, K., Blagg, B. S. J., Neckers, L., Helquist, P. M., Wiest, O., et al. (2021) · Journal of Lipid Research · doi:10.1016/j.jlr.2021.100114 · Cited by 17 · see citing works

Current advancements in therapy for Niemann-Pick disease: progress and pitfalls

Brémovà-Ertl, T., & Schneider, S. A. (2023) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2023.2215386 · Cited by 16 · see citing works

mRNA Treatment Rescues Niemann–Pick Disease Type C1 in Patient Fibroblasts

Furtado, D. L., Cortez‐Jugo, C., Hung, Y. H., Bush, A. I., & Caruso, F. (2022) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.2c00463 · Cited by 16 · see citing works

Cleavage of Hsp70.1 causes lysosomal cell death under stress conditions

Yamashima, T., Mochly‐Rosen, D., Soichi Wakatsuki, A., Mizukoshi, E., Seike, T., Larus, I., Chen, C., Takemura, M., Saitō, H., & Ohashi, A. (2024) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2024.1378656 · Cited by 15 · see citing works

Identification of proteotoxic and proteoprotective bacteria that non-specifically affect proteins associated with neurodegenerative diseases

Walker, A. C., Bhargava, R., Bucher, M. J., Argote, Y. M., Brust, A. S., & Czyż, D. M. (2024) · iScience · doi:10.1016/j.isci.2024.110828 · Cited by 15 · see citing works

Protecting Encapsulin Nanoparticles with Cysteine-Knot Miniproteins

Klem, R., de Ruiter, M. V., & Cornelissen, J. J. L. M. (2018) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.8b00630 · Cited by 15 · see citing works

Conformational dynamics of free and membrane-bound human Hsp70 in model cytosolic and endo-lysosomal environments

Calvaresi, V., Truelsen, L. T., Larsen, S. B., Petersen, N. H. T., Kirkegaard, T., & Rand, K. D. (2021) · Communications Biology · doi:10.1038/s42003-021-02892-7 · Cited by 15 · see citing works

The expanding boundaries of sphingolipid lysosomal storage diseases; insights from Niemann–Pick disease type C

Platt, F. M. (2023) · Biochemical Society Transactions · doi:10.1042/bst20220711 · Cited by 14 · see citing works

Arimoclomol: First Approval

Keam, S. J. (2024) · Drugs · doi:10.1007/s40265-024-02129-x · Cited by 14 · see citing works

A cross‐sectional, prospective ocular motor study in 72 patients with Niemann‐Pick disease type C

Brémovà-Ertl, T., Abel, L. A., Walterfang, M., Salsano, E., Ardissone, A., Malinová, V., Kolníková, M., Bayarri, J. G., Tavasoli, A. R., Ashrafi, M. R., et al. (2021) · European Journal of Neurology · doi:10.1111/ene.14955 · Cited by 14 · see citing works

Ellagic acid and its metabolites urolithins A/B ameliorate most common disease phenotypes in cellular and mouse models for lysosomal storage disorders by enhancing extracellular vesicle secretion

Soto‐Huelin, B., Babiy, B., Pastor, Ó., Díaz-García, M., Toledano‐Zaragoza, A., Frutos, M. D., Espı́n, J. C., Tomás-Barberán, F. A., Busto, R., & Ledesma, M. D. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106141 · Cited by 14 · see citing works

Correlation of age of onset and clinical severity in Niemann–Pick disease type C1 with lysosomal abnormalities and gene expression

Baxter, L. L., Watkins‐Chow, D. E., Johnson, N. L., Farhat, N. Y., Platt, F. M., Dale, R., Porter, F. D., Pavan, W. J., & Rodriguez‐Gil, J. L. (2022) · Scientific Reports · doi:10.1038/s41598-022-06112-y · Cited by 13 · see citing works

Heat shock protein amplification improves cerebellar myelination in the Npc1nih mouse model

Gray, J., Fernández‐Suárez, M. E., Falah, M. M., Smith, D. A., Smith, C., Kaya, E., Palmer, A. M., Fog, C. K., Kirkegaard, T., & Platt, F. M. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2022.104374 · Cited by 13 · see citing works

Mass spectrometry-based proteomics in neurodegenerative lysosomal storage disorders

Li, W., & Cologna, S. M. (2022) · Molecular Omics · doi:10.1039/d2mo00004k · Cited by 12 · see citing works

Mechanistic insights into arimoclomol mediated effects on lysosomal function in Niemann-pick type C disease

Shammas, H., Fog, C. K., Klein, P., Koustrup, A., Pedersen, M. T., Bie, A. S., Mickle, T. C., Petersen, N. H. T., Jensen, T. K., & Guenther, S. M. (2025) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2025.109103 · Cited by 12 · see citing works

Tolerance of chronic HDACi treatment for neurological, visceral and lung Niemann-Pick Type C disease in mice

Alam†, M. S., Cooper, B. R., Farris, J. D., & Haldar, K. (2018) · Scientific Reports · doi:10.1038/s41598-018-22162-7 · Cited by 11 · see citing works

Transcript, protein, metabolite and cellular studies in skin fibroblasts demonstrate variable pathogenic impacts of NPC1 mutations

Mušálková, D., Majer, F., Kuchař, L., Lukšan, O., Asfaw, B., Vlášková, H., Štorkánová, G., Řeboun, M., Poupětová, H., Jahnová, H., et al. (2020) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-020-01360-5 · Cited by 10 · see citing works

Assessment of FDA-Approved Drugs as a Therapeutic Approach for Niemann-Pick Disease Type C1 Using Patient-Specific iPSC-Based Model Systems

Völkner, C., Pantoom, S., Liedtke, M., Lukáš, J., Hermann, A., & Frech, M. J. (2022) · Cells · doi:10.3390/cells11030319 · Cited by 10 · see citing works

HSP70 reverses lysosomal pathology

Crunkhorn, S. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.220 · Cited by 2 · see citing works

Modulating the heat-shock response : a potential therapy for lysosomal storage disorders

Gray, J. A. R. (2014) · Oxford University Research Archive (ORA) (University of Oxford) · doi:10.5287/ora-gp70p2zao

Hsp70 stabilizes lysosomes and reverts Niemann–Pick disease-associated lysosomal pathology

Kirkegaard, T., Roth, A. G., Petersen, N. H. T., Mahalka, A. K., Olsen, O. D., Moilanen, I., Zylicz, A., Knudsen, J., Sandhoff, K., Arenz, C., et al. (2010) · Nature · doi:10.1038/nature08710 · Cited by 519 · see citing works

Heat shock protein 70 (Hsp70)

(2010) · Science-Business eXchange · doi:10.1038/scibx.2010.193

Delivery of recombinant proteins via the cerebrospinal fluid as a therapy option for neurodegenerative lysosomal storage diseases

Hemsley, K. M., & Hopwood, J. J. (2009) · International Journal of Clinical Pharmacology and Therapeutics · doi:10.5414/cpp47118 · Cited by 29 · see citing works